ST
ARIA

Spot Trading’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Spot Trading’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-20,700
Closed -$153K – 3832
2016
Q2 		$153K Buy
+20,700
New +$155K ﹤0.01% 2371
2016
Q1 		– Sell
-41,723
Closed -$261K – 4388
2015
Q4 		$261K Sell
41,723
-10,960
-21% -$71.9K ﹤0.01% 2319
2015
Q3 		$308K Buy
52,683
+34,194
+185% +$263K ﹤0.01% 2389
2015
Q2 		$153K Sell
18,489
-40,838
-69% -$361K ﹤0.01% 2863
2015
Q1 		$489K Sell
59,327
-14,261
-19% -$105K ﹤0.01% 2129
2014
Q4 		$506K Sell
73,588
-60,231
-45% -$377K ﹤0.01% 2340
2014
Q3 		$723K Buy
133,819
+40,720
+44% +$238K ﹤0.01% 2308
2014
Q2 		$593K Buy
93,099
+91,170
+4,726% +$627K ﹤0.01% 2558
2014
Q1 		$16K Sell
1,929
-49,717
-96% -$387K ﹤0.01% 3871
2013
Q4 		$352K Buy
51,646
+44,850
+660% +$242K ﹤0.01% 2707
2013
Q3 		$125K Buy
6,796
+1,199
+21% +$23.3K ﹤0.01% 3261
2013
Q2 		$98K Buy
+5,597
New +$99.2K ﹤0.01% 3448

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Spot Trading's ARIA Position: Q3 2016 in Review

Spot Trading sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 20,700 shares — an estimated $153K sold.

Spot Trading first reported a position in ARIA in Q2 2013 and held it in 12 quarters. The position peaked at $723K in Q3 2014. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Spot Trading reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Spot Trading sold 20,700 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $153K.
  • Spot Trading first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
  • Spot Trading's Ariad Pharmaceuticals Inc position peaked at $723K in Q3 2014.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Spot Trading's 13F filing for Q3 2016, filed 31 Oct 2016.